000 01434 a2200409 4500
005 20250515181316.0
264 0 _c20100311
008 201003s 0 0 eng d
022 _a1365-2133
024 7 _a10.1111/j.1365-2133.2009.09305.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGazerani, P
245 0 0 _aBotulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
_h[electronic resource]
260 _bThe British journal of dermatology
_cOct 2009
300 _a737-45 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAntipruritics
_xadministration & dosage
650 0 4 _aBotulinum Toxins, Type A
_xadministration & dosage
650 0 4 _aDermatitis
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aHistamine
650 0 4 _aHumans
650 0 4 _aLaser-Doppler Flowmetry
650 0 4 _aMale
650 0 4 _aProspective Studies
650 0 4 _aPruritus
_xchemically induced
650 0 4 _aSkin
_xblood supply
650 0 4 _aSkin Tests
650 0 4 _aThermography
650 0 4 _aVasoconstriction
_xdrug effects
700 1 _aPedersen, N S
700 1 _aDrewes, A M
700 1 _aArendt-Nielsen, L
773 0 _tThe British journal of dermatology
_gvol. 161
_gno. 4
_gp. 737-45
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.2009.09305.x
_zAvailable from publisher's website
999 _c19033266
_d19033266